Latest Breaking News On - Philip taylor gilmartin group - Page 1 : comparemela.com
Chembio Diagnostics (CEMI) Announces the Receipt of CLIA Waiver for its DPP HIV-Syphilis System
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Chembio Diagnostics (CEMI) Acquired by Biosynex for $0 45/sh
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Biosynex and Chembio Diagnostics Announce Definitive Acquisition Agreement
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Chembio Diagnostics Appoints David Acheson, M.D. to its Board of Directors
Chembio Diagnostics Appoints David Acheson, M.D. to its Board of Directors
HAUPPAUGE, N.Y., Dec. 17, 2020 Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the appointment of David Acheson, M.D. to the Company’s Board of Directors.
“We are pleased to welcome David to our Board of Directors. He adds directly applicable expertise in public health and infectious disease management to our leadership team, and we are confident his perspective will contribute meaningfully to our long-term value creation strategy,” said Katherine L. Davis, Chair of Chembio’s Board of Directors. “We look forward to his leadership and insights as we enter the next phase of growth for Chembio.”